ZATTONI, FABIO
 Distribuzione geografica
Continente #
NA - Nord America 9.053
AS - Asia 5.839
EU - Europa 3.345
SA - Sud America 1.534
AF - Africa 1.465
OC - Oceania 139
Continente sconosciuto - Info sul continente non disponibili 71
AN - Antartide 1
Totale 21.447
Nazione #
US - Stati Uniti d'America 8.192
SG - Singapore 1.995
BR - Brasile 1.020
CN - Cina 956
IT - Italia 678
HK - Hong Kong 647
VN - Vietnam 614
DE - Germania 272
PL - Polonia 253
FI - Finlandia 202
NL - Olanda 177
FR - Francia 162
RU - Federazione Russa 153
GB - Regno Unito 142
IN - India 103
KR - Corea 103
AR - Argentina 101
MX - Messico 101
SE - Svezia 100
BJ - Benin 86
ID - Indonesia 86
ES - Italia 85
TR - Turchia 84
CA - Canada 83
AT - Austria 80
JP - Giappone 77
CH - Svizzera 69
EC - Ecuador 68
ZA - Sudafrica 68
IE - Irlanda 64
CI - Costa d'Avorio 57
IQ - Iraq 52
NI - Nicaragua 52
UA - Ucraina 52
UZ - Uzbekistan 52
DO - Repubblica Dominicana 51
IR - Iran 51
PY - Paraguay 51
LB - Libano 50
AE - Emirati Arabi Uniti 49
JO - Giordania 49
KG - Kirghizistan 49
PE - Perù 49
VE - Venezuela 48
GT - Guatemala 47
LA - Repubblica Popolare Democratica del Laos 47
SA - Arabia Saudita 47
EG - Egitto 46
RS - Serbia 46
YT - Mayotte 46
AL - Albania 45
CO - Colombia 45
HN - Honduras 44
SK - Slovacchia (Repubblica Slovacca) 44
UY - Uruguay 44
CR - Costa Rica 43
CV - Capo Verde 43
PA - Panama 43
TJ - Tagikistan 43
BE - Belgio 42
GR - Grecia 42
MU - Mauritius 42
BG - Bulgaria 41
GA - Gabon 41
KE - Kenya 41
LV - Lettonia 41
ML - Mali 41
NO - Norvegia 41
NP - Nepal 41
TN - Tunisia 41
BY - Bielorussia 40
CL - Cile 40
IL - Israele 40
KZ - Kazakistan 40
PK - Pakistan 40
BZ - Belize 39
HU - Ungheria 39
JM - Giamaica 39
MA - Marocco 39
AO - Angola 38
DZ - Algeria 38
IS - Islanda 38
MY - Malesia 38
BS - Bahamas 37
CD - Congo 37
CW - ???statistics.table.value.countryCode.CW??? 37
CY - Cipro 37
GH - Ghana 37
PS - Palestinian Territory 37
TT - Trinidad e Tobago 37
BW - Botswana 36
EE - Estonia 36
GF - Guiana Francese 36
KH - Cambogia 36
AF - Afghanistan, Repubblica islamica di 35
AZ - Azerbaigian 35
CU - Cuba 35
GN - Guinea 35
LC - Santa Lucia 35
MK - Macedonia 35
Totale 19.781
Città #
Fairfield 1.199
Singapore 1.074
Ashburn 1.048
Hong Kong 603
Woodbridge 537
Chandler 474
Seattle 444
Houston 429
Cambridge 387
Wilmington 376
Ann Arbor 317
Santa Clara 294
Beijing 264
Boardman 211
Bytom 185
Dong Ket 185
Ho Chi Minh City 163
San Diego 140
Los Angeles 122
Princeton 119
Medford 117
Munich 112
Helsinki 108
Padova 107
Hefei 104
Des Moines 91
Hanoi 86
São Paulo 85
Cotonou 80
Guangzhou 80
New York 78
Milan 70
Chicago 66
Seoul 64
Roxbury 57
Abidjan 54
Buffalo 54
Dublin 51
Managua 50
Amman 49
Tokyo 48
Tashkent 47
Nanjing 46
Warsaw 46
Bamako 41
Vienna 41
Dushanbe 40
Libreville 40
Panama City 40
Vientiane 40
Montevideo 38
Rio de Janeiro 38
Bishkek 37
Nairobi 37
Montreal 36
Nassau 36
Praia 36
Shanghai 36
Turku 36
Phnom Penh 35
Castries 34
Conakry 34
Johannesburg 34
Lima 34
Riga 34
Accra 33
Luanda 33
Dakar 32
Harare 31
Reykjavik 31
Rome 31
Zurich 31
Bridgetown 30
Lusaka 30
Baku 29
Havana 29
Kampala 29
Nuremberg 29
Willemstad 29
Antananarivo 28
Guatemala City 28
Kingston 28
Niamey 28
Nouakchott 28
Podgorica 28
Stockholm 28
Tallinn 28
Belo Horizonte 27
Lappeenranta 27
San José 27
Sofia 27
Yerevan 27
Addis Ababa 26
Cayenne 26
Jakarta 26
Kinshasa 26
Dili 25
Minsk 25
Ulan Bator 25
Dallas 24
Totale 12.087
Nome #
A 10-year history of secondary hypertension: A challenging case of renin-secreting juxtaglomerular cell tumor 310
The Neutrophil-to-Lymphocyte Ratio as a Prognostic Factor for Patients with Urothelial Carcinoma of the Bladder Following Radical Cystectomy 270
Technical innovations to optimize continence recovery after robotic assisted radical prostatectomy 254
10-Year Clinical Experience with 18F-Choline PET/CT: An Italian Multicenter Retrospective Assessment of 3343 Patients 243
The value of open conversion simulations during robot-assisted radical prostatectomy: Implications for robotic training curricula 241
Complex cystine kidney stones treated with combined robot-assisted laparoscopic pyelolithotomy and intraoperative renoscopy 235
PET/MRI in prostate cancer: a systematic review and meta-analysis 207
Fluorocholine PET/CT predicts skeletal progression, skeletal event and cancer specific survival in patients with biochemical relapse for prostate cancer 204
18F-FDG PET/CT and urothelial carcinoma: Impact on management and prognosis—a multicenter retrospective study 202
Comparison between the diagnostic accuracies of 18F-fluorodeoxyglucose positron emission tomography/computed tomography and conventional imaging in recurrent urothelial carcinomas: a retrospective, multicenter study 197
Spermatic Cord Sarcoma: Our Experience and Review of the Literature 193
18F-fluoromethylcholine or 18F-fluoroethylcholine pet for prostate cancer imaging: Which is better? A literature revision 191
Comparison between conventional imaging (abdominal-pelvic computed tomography and bone scan) and [18F]choline positron emission tomography/computed tomography imaging for the initial staging of patients with intermediate- tohigh-risk prostate cancer: A retrospective analysis 188
Histopathological characteristics of microfocal prostate cancer detected during systematic prostate biopsy. 182
Development of a Surgical Safety Training Program and Checklist for Conversion during Robotic Partial Nephrectomies 180
Ultrasound-guided transversus abdominis plane block (US-TAPb) for robot-assisted radical prostatectomy: a novel ‘4-point’ technique—results of a prospective, randomized study 178
Effect of allogeneic intraoperative blood transfusion on survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution 177
Urinary microbiome and urological cancers: a mini review 176
Recurrent renal cell carcinoma: clinical and prognostic value of FDG PET/CT 169
MP79-02 EVALUATION OF THE PROGNOSTIC IMPACT OF 18F-CHOLINE PET/CT IN PATIENTS WITH SKELETAL RECURRENCE PROSTATE CANCER 168
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 167
Can 68GA-PSMA or radiolabeled choline PET/CT guide salvage lymph node dissection in recurrent prostate cancer? 163
Combined robotic-assisted retroperitoneoscopic partial nephrectomy and extraperitoneal prostatectomy. First case reported. 161
Endourologic Diagnosis and Robotic Treatment of a Giant Fibroepithelial Polyp of the Ureter 159
Thyroid-like follicular carcinoma of the kidney: report of two cases with detailed immunohistochemical profile and literature review. 159
Key strategies for reducing recurrence in T1 bladder cancer. Evidence from a retrospective multicenter European study 158
PD36-03 PERIOPERATIVE OUTCOMES OF OPEN RADICAL CYSTECTOMY IN OCTOGENARIANS: RESULTS FROM TWO HIGH-VOLUME CENTRES 157
Multimodal treatment for high-risk prostate cancer with high-dose intensity-modulated radiation therapy preceded or not by radical prostatectomy, concurrent intensified-dose docetaxel and long-term androgen deprivation therapy: results of a prospective phase II trial. 157
Multimodal treatment for high-risk locally-advanced prostate cancer following radical prostatectomy and extended lymphadenectomy 155
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 154
Should radical prostatectomy be encouraged at any age? A critical non-systematic review 152
The impact of COVID-19 pandemic on pornography habits: a global analysis of Google Trends 150
PD11-01 COMPARISON BETWEEN THE DIAGNOSTIC ACCURACIES OF 18F-FLUORODEOXYGLUCOSE (FDG) POSITRON EMISSION TOMOGRAPHY (PET)/COMPUTED TOMOGRAPHY (CT) AND MORPHOLOGICAL IMAGING IN RECURRENT UROTHELIAL CARCINOMAS: A RETROSPECTIVE, MULTI-CENTER STUDY 149
Navigating the evolving diagnostic and therapeutic landscape of low- and intermediate-risk prostate cancer 148
Radiolabelled choline and FDG PET/CT: two alternatives for the assessment of lymph node metastases in patients with upper urinary tract urothelial carcinoma 148
Comparing long-term outcomes of primary and progressive carcinoma invading bladder muscle after radical cystectomy 148
Retzius-sparing Robot-assisted Simple Prostatectomy: Perioperative and Short-term Functional Outcomes Assessed via Validated Questionnaires 145
Perioperative outcomes and early survival in octogenarians who underwent radical cystectomy for bladder cancer 145
Why and How to Evaluate Chronic Prostatic Inflammation 144
Choline PET or PET/CT and biochemical relapse of prostate cancer: a systematic review and meta-analysis. 144
Oncologic Outcomes of Incidental Versus Biopsy-diagnosed Grade Group 1 Prostate Cancer: A Multi-institutional Study 143
Re: Michael S. Hofman, Nathan Lawrentschuk, Roslyn J. Francis, et al. Prostate-specific Membrane Antigen PET-CT in Patients with High-risk Cancer Before Curative-intent Surgery or Radiotherapy (proPSMA): A Prospective, Randomized, Multicenter Study. Lancet 2020;395:1208–16 143
The Endourological Treatment of Renal Matrix Stones 141
MP55-05 PARTIAL NEPHRECTOMY IN THE TREATMENT OF RENAL TUMORS WITH CONCOMITANT VENOUS TUMOR THROMBOSIS (VTT) OF RENAL VEIN BRANCHES: RETROSPECTIVE, MULTI-CENTER ANALYSIS OF PERIOPERATIVE, FUNCTIONAL, AND ONCOLOGIC OUTCOMES 141
A Prospective Randomized Multicenter Study on the Impact of [18F]F-Choline PET/CT Versus Conventional Imaging for Staging Intermediate- to High-Risk Prostate Cancer 140
Global minimally invasive pyeloplasty study in children: Results from the Pediatric Urology Expert Group of the European Association of Urology Young Academic Urologists working party 139
MP59-08 EXTERNAL VALIDATION OF RENAL TUMOUR CONTACT SURFACE AREA (CSA) IN PATIENTS WHO UNDERWENT PARTIAL NEPHRECTOMY 139
Prostate cancer: more effective use of underutilized postoperative radiation therapy 139
Wunderlich's syndrome: three cases of acute spontaneous renal bleeding, conservatively treated. 138
THE WAR IS OPENED: PSMA VS. 64CuCL2 VS. CHOLINE PET/CT 138
Study Protocol for the DETECTIVE Study: An International Collaborative Study To Develop Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer 138
An updated model for predicting side-specific extraprostatic extension in the era of MRI-targeted biopsy 137
PD19-01 THE VALUE OF OPEN CONVERSION SIMULATIONS DURING ROBOT-ASSISTED RADICAL PROSTATECTOMY: IMPLICATIONS FOR ROBOTIC TRAINING CURRICULUMS 137
68Ga-dotatoc vs.18F-FDG vs. radiolabelled PSMA PET/CT in renal cancer patients 136
The effects of androgen deprivation therapy on the 18F-choline uptake in prostate cancer patients undergoing neoadjuvant treatment 135
ULTRASOUND DETECTED NON-PALPABLE TESTICULAR LESIONS: WHAT DO YOU DO? 135
EAU-EANM-ESTRO-ESUR-SIOG Prostate Cancer Guideline Panel Consensus Statements for Deferred Treatment with Curative Intent for Localised Prostate Cancer from an International Collaborative Study (DETECTIVE Study) 135
RETROGRADE INTRA RENAL SURGERY FOR RENAL STONES 135
THE ENDOUROLOGICAL TREATMENT OF RENAL MATRIX STONES 134
Perioperative, Oncological, and Functional Outcomes of New Multiport Robotic Platforms in Urology: A Systematic Review and Meta-analysis 133
Minimally invasive urologic surgery is safe during COVID-19: experience from two high-volume centers in Italy 133
Relevance of the Endoscopic Evaluation in the Diagnosis of Bladder Pain Syndrome/Interstitial Cystitis 133
Metabolic syndrome and prostate cancer treatment 133
Metabolic syndrome and stone disease 133
Re: Evelien J.E. van Altena, Bernard H.E. Jansen, Marieke L. Korbee, et al. Prostate-specific Membrane Antigen Positron Emission Tomography Before Reaching the Phoenix Criteria for Biochemical Recurrence of Prostate Cancer After Radiotherapy: Earlier Detection of Recurrences. Eur Urol Oncol. In press. https://doi.org/10.1016/j.euo.2024.09.015 129
Correlation between pathologic features and perfusion CT of renal cancer: a feasibility study. 129
Early detection of prostate cancer relapse by biochemistry and diagnostic imaging 129
Detection of recurrent prostate cancer after primary radiation therapy: An evaluation of the role of multiparametric 3T magnetic resonance imaging with endorectal coil 128
RETROGRADE INTRA RENAL SURGERY (RIRS) FOR RENAL STONES 128
Erratum: Why and how to evaluate chronic prostatic inflammation (European Urology (2013) 12:SUPPL. (110-5)) 128
The future of choline pet in the era of PMSA 127
Transitional cell carcinoma recurrence impacting intestinal diversion after radical cystectomy. Oncologic outcomes of a rare site of recurrence 127
Natural History of Clinical Recurrence Patterns of Lymph Node-Positive Prostate Cancer after Radical Prostatectomy 126
Vaginal cuff recurrence after radical cystectomy: an under - studied site of bladder cancer relapse 125
Utility of Choline Positron Emission Tomography/Computed Tomography for Lymph Node Involvement Identification in Intermediate- to High-risk Prostate Cancer: A Systematic Literature Review and Meta-analysis. 124
Outcomes of Cytoreductive Radical Prostatectomy for Oligometastatic Prostate Cancer on Prostate-specific Membrane Antigen Positron Emission Tomography: Results of a Multicenter European Study 123
The Future of Choline PET in the Era of Prostate Specific Membrane Antigen 123
MP57-13 LAPAROSCOPIC VERSUS PERCUTANEOUS CRYOABLATION FOR T1 RENAL MASSES: AN ITALIAN MULTICENTRIC STUDY 122
Role of radiomic analysis of [18F]fluoromethylcholine PET/CT in predicting biochemical recurrence in a cohort of intermediate and high risk prostate cancer patients at initial staging 121
Is "extreme" bladder neck preservation in robot-assisted radical prostatectomy a safe procedure? 120
Abbreviated Versus Multiparametric Prostate MRI in Active Surveillance for Prostate-Cancer Patients: Comparison of Accuracy and Clinical Utility as a Decisional Tool 119
PSMA PET-targeted Biopsy for Prostate Cancer Diagnosis: Initial Experience From a Multicenter Cohort 119
PD12-12 COMPLICATION RATES AFTER RADICAL CYSTECTOMY AFTER RADIOTHERAPY: AN INTERNATIONAL, MULTICENTER RETROSPECTIVE STUDY ON 609 CASES 119
Perioperative and Functional Results for Robot-assisted Radical Cystectomy with Totally Intracorporeal Neobladder in Male Patients via the Vesica Patavina (Ves.Pa.) Technique: IDEAL Stage 2a Report 118
Is 11C-choline Positron Emission Tomography/Computed Tomography Accurate to Detect Nodal Relapses of Prostate Cancer After Biochemical Recurrence? A Multicentric Study Based on Pathologic Confirmation from Salvage Lymphadenectomy 118
Predictive value of negative 3T multiparametric magnetic resonance imaging of the prostate on 12-core biopsy results 116
Urology: a trip into metaverse 115
PET/MRI in prostate cancer: a systematic review and meta-analysis 114
Posterior muscolofascial reconstruction incorporated into urethrovescical anastomosis during robot-assisted radical prostatectomy 113
Focal Therapy for Prostate Cancer: Complications and Their Treatment 113
Income inequality and treatment of African American men with high-risk prostate cancer 112
Adjuvant radiation therapy or observation with or without early salvage radiation therapy for men with node positive prostate cancer after surgery and negative pre-operative conventional imaging: a multicenter study 110
CLINICAL EVOLUTION OF THE RENAL COLIC. AN OBSERVATIONAL STUDY 110
Diagnosis of clinically significant prostate cancer after negative multiparametric magnetic resonance imaging 109
Risk Stratification of pN+ Prostate Cancer after Radical Prostatectomy from a Large Single Institutional Series with Long-Term Followup 109
Treating cervico-urethral obstructions with laser diode: initial clinical experience. 109
Preoperative chronic kidney disease before radical cystectomy as predictor of oncological outcomes: a pick of the iceberg? 108
Radiotherapy and concomitant docetaxel in high risk prostatic cancer:guone (north east uro oncology group) experience. 107
Role of targeted biopsy, perilesional biopsy, and random biopsy in prostate cancer diagnosis by mpMRI/transrectal ultrasonography fusion biopsy 107
Risk stratification for benign prostatic hyperplasia 106
Totale 14.776
Categoria #
all - tutte 68.239
article - articoli 65.199
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 201
Totale 133.639


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021772 0 0 0 0 0 57 57 93 128 114 104 219
2021/20221.556 45 183 162 87 66 158 127 132 68 76 119 333
2022/20231.091 238 82 20 112 157 137 26 66 120 10 87 36
2023/20241.022 43 106 98 64 58 85 80 64 58 131 118 117
2024/20254.123 24 315 164 166 462 130 130 364 390 199 665 1.114
2025/20269.948 833 1.575 2.627 3.159 1.725 29 0 0 0 0 0 0
Totale 21.704